CICLESONIDE

CICLESONIDE was reported 13741 times

CICLESONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLETHYSMOGRAPHY 25 0.9615
1 CFTR GENE MUTATION 20 0.8000
2 AIRWAY REMODELLING 96 0.7742
3 BRONCHOLITHIASIS 22 0.7097
4 INSPIRATORY CAPACITY ABNORMAL 18 0.6429
5 TOTAL LUNG CAPACITY INCREASED 169 0.6213
6 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 306 0.5851
7 SPIROMETRY ABNORMAL 330 0.5518
8 CENTRAL NERVOUS SYSTEM MASS 51 0.5368
9 CONGENITAL HIATUS HERNIA 121 0.5307
10 MITE ALLERGY 320 0.4885
11 HYPER IGE SYNDROME 55 0.4825
12 LUNG DIFFUSION TEST ABNORMAL 46 0.4742
13 WALL MOTION SCORE INDEX ABNORMAL 51 0.4636
14 MUSCLE TENSION DYSPHONIA 30 0.3750
15 BRONCHIAL NEOPLASM 50 0.3676
16 MYCOTIC ALLERGY 313 0.3661
17 FORCED EXPIRATORY VOLUME 12 0.3429
18 DUST ALLERGY 330 0.3364
19 PULMONARY VASCULITIS 166 0.3086
20 TYMPANOSCLEROSIS 15 0.3061
21 TOTAL LUNG CAPACITY ABNORMAL 118 0.3033
22 CAPILLARITIS 70 0.2536
23 ATOPY 64 0.2302
24 CONJUNCTIVITIS ALLERGIC 331 0.2233
25 BRONCHIAL WALL THICKENING 151 0.2100
26 FORCED EXPIRATORY FLOW DECREASED 20 0.2062
27 EOSINOPHIL COUNT 22 0.1897
28 LARYNGEAL DYSKINESIA 24 0.1860
29 EOSINOPHILIC PNEUMONIA CHRONIC 55 0.1852
30 FORCED EXPIRATORY VOLUME DECREASED 510 0.1798
31 REVERSIBLE AIRWAYS OBSTRUCTION 88 0.1732
32 RIB DEFORMITY 43 0.1693
33 OBSTRUCTIVE AIRWAYS DISORDER 1848 0.1660
34 EOSINOPHILIC BRONCHITIS 33 0.1650
35 BRONCHIAL HAEMORRHAGE 51 0.1635
36 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 32 0.1633
37 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 115 0.1569
38 EOSINOPHIL COUNT ABNORMAL 116 0.1553
39 BACTERIAL DISEASE CARRIER 105 0.1440
40 VENTRICULAR FAILURE 45 0.1438
41 BLOOD IMMUNOGLOBULIN E DECREASED 23 0.1429
42 NASAL TURBINATE HYPERTROPHY 52 0.1379
43 ENDOMETRIAL ABLATION 49 0.1373
44 RESTRICTIVE PULMONARY DISEASE 159 0.1357
45 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 265 0.1298
46 BRONCHOMALACIA 17 0.1288
47 MALIGNANT MELANOMA STAGE 0 26 0.1244
48 NEUROSENSORY HYPOACUSIS 15 0.1240
49 LUNG DIFFUSION DISORDER 19 0.1210
50 SPUTUM PURULENT 79 0.1201
51 VOCAL CORD DYSFUNCTION 56 0.1136
52 LYMPH NODE CALCIFICATION 22 0.1134
53 BLOOD IMMUNOGLOBULIN E INCREASED 271 0.1118
54 BRONCHIAL SECRETION RETENTION 141 0.1107
55 FIBROMUSCULAR DYSPLASIA 18 0.1098
56 NEURITIS 169 0.1094
57 ASTHMA EXERCISE INDUCED 38 0.1092
58 FULL BLOOD COUNT ABNORMAL 1072 0.1013
59 NORMOCHROMIC NORMOCYTIC ANAEMIA 303 0.1008
60 SOFT TISSUE DISORDER 105 0.0947
61 BRONCHIAL HYPERREACTIVITY 113 0.0939
62 RESPIRATORY SYMPTOM 265 0.0931
63 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1504 0.0885
64 BRONCHIECTASIS 591 0.0876
65 OESOPHAGEAL POLYP 16 0.0847
66 FACTOR V LEIDEN MUTATION 33 0.0831
67 FORCED EXPIRATORY VOLUME ABNORMAL 12 0.0828
68 VENOUS PRESSURE JUGULAR INCREASED 30 0.0826
69 VITAL CAPACITY DECREASED 37 0.0826
70 NASAL POLYPS 405 0.0822
71 FORCED VITAL CAPACITY DECREASED 52 0.0796
72 LARYNGEAL STENOSIS 46 0.0796
73 PEAK EXPIRATORY FLOW RATE DECREASED 34 0.0773
74 BREATH SOUNDS ABNORMAL 377 0.0764
75 RHONCHI 103 0.0745
76 RESPIRATORY GAS EXCHANGE DISORDER 27 0.0728
77 EXPOSURE TO ALLERGEN 23 0.0721
78 SPUTUM DISCOLOURED 676 0.0712
79 HUMIDITY INTOLERANCE 28 0.0700
80 EOSINOPHILIC MYOCARDITIS 51 0.0699
81 ADRENAL SUPPRESSION 58 0.0688
82 RESPIRATORY TRACT INFLAMMATION 32 0.0687
83 PULMONARY FUNCTION TEST ABNORMAL 107 0.0686
84 CARDIAC SEPTAL DEFECT 49 0.0682
85 MALIGNANT MELANOMA IN SITU 84 0.0678
86 NASAL OBSTRUCTION 125 0.0666
87 DIAPHRAGMATIC DISORDER 49 0.0641
88 WHEEZING 3758 0.0633
89 PARANASAL SINUS INFLAMMATION 13 0.0586
90 CRYSTAL ARTHROPATHY 12 0.0571
91 LUNG HYPERINFLATION 49 0.0570
92 PULMONARY FUNCTION TEST DECREASED 243 0.0555
93 ALLERGY TO ANIMAL 59 0.0553
94 MICROANGIOPATHY 52 0.0553
95 PNEUMONIA VIRAL 175 0.0548
96 RHINITIS ALLERGIC 243 0.0545
97 LUNG DIFFUSION TEST DECREASED 21 0.0526
98 ASTHMA 5918 0.0523
99 SMOKE SENSITIVITY 16 0.0519
100 NASAL MUCOSAL DISORDER 30 0.0515
101 CHRONIC SINUSITIS 192 0.0511
102 PRESBYACUSIS 15 0.0487
103 PLEURAL THICKENING 33 0.0482
104 SUPERINFECTION 72 0.0480
105 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 30 0.0467
106 SINUS PAIN 104 0.0446
107 BRONCHIAL DISORDER 69 0.0443
108 SOFT TISSUE SWELLING 25 0.0440
109 EOSINOPHIL COUNT INCREASED 362 0.0434
110 BLOOD COUNT ABNORMAL 651 0.0429
111 BRONCHIAL OBSTRUCTION 59 0.0420
112 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 38 0.0410
113 ARTERIOSCLEROSIS CORONARY ARTERY 271 0.0409
114 RHINITIS 326 0.0404
115 HEART RATE 14 0.0402
116 SARCOIDOSIS 184 0.0387
117 SINUS POLYP 22 0.0381
118 INCREASED BRONCHIAL SECRETION 97 0.0379
119 SECONDARY IMMUNODEFICIENCY 46 0.0379
120 MYCOBACTERIUM AVIUM COMPLEX INFECTION 101 0.0376
121 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1799 0.0374
122 POLYCYSTIC OVARIES 58 0.0374
123 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2612 0.0367
124 CREPITATIONS 107 0.0359
125 SPUTUM INCREASED 77 0.0356
126 NEUROLOGICAL SYMPTOM 188 0.0329
127 NASAL DISCHARGE DISCOLOURATION 45 0.0326
128 PRODUCTIVE COUGH 1551 0.0325
129 KYPHOSIS 57 0.0322
130 HYPOVENTILATION 104 0.0319
131 JAUNDICE CHOLESTATIC 110 0.0311
132 HAEMOPHILUS INFECTION 30 0.0306
133 PULMONARY ALVEOLAR HAEMORRHAGE 171 0.0305
134 HERNIA PAIN 14 0.0304
135 ARTERIOSCLEROSIS 283 0.0300
136 RALES 174 0.0299
137 HYPOMANIA 110 0.0299
138 LUNG CONSOLIDATION 82 0.0293
139 ALLERGIC SINUSITIS 25 0.0291
140 UPPER-AIRWAY COUGH SYNDROME 235 0.0285
141 TOTAL LUNG CAPACITY DECREASED 45 0.0282
142 IMMUNISATION REACTION 20 0.0278
143 RECTAL PROLAPSE 33 0.0273
144 NODULE 356 0.0273
145 FOREARM FRACTURE 19 0.0272
146 RESPIRATORY TRACT OEDEMA 20 0.0270
147 PANCREATITIS RELAPSING 22 0.0269
148 CHEST X-RAY ABNORMAL 79 0.0257
149 SYSTOLIC DYSFUNCTION 27 0.0256
150 THROAT CLEARING 96 0.0256
151 LOWER RESPIRATORY TRACT CONGESTION 43 0.0253
152 BENIGN PROSTATIC HYPERPLASIA 129 0.0250
153 LIP PRURITUS 21 0.0245
154 LIPOHYPERTROPHY 15 0.0241
155 GRANULOMATOSIS WITH POLYANGIITIS 29 0.0240
156 SINUS OPERATION 57 0.0239
157 ANIMAL SCRATCH 23 0.0236
158 DYSPNOEA PAROXYSMAL NOCTURNAL 17 0.0233
159 OBSTRUCTIVE SLEEP APNOEA SYNDROME 34 0.0233
160 MIDDLE INSOMNIA 433 0.0232
161 EOSINOPHILIC PNEUMONIA 72 0.0228
162 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 15 0.0225
163 EOSINOPHIL COUNT DECREASED 53 0.0222
164 BODY TEMPERATURE DECREASED 212 0.0215
165 TERMINAL INSOMNIA 38 0.0214
166 IDIOPATHIC INTRACRANIAL HYPERTENSION 48 0.0213
167 TONSIL CANCER 17 0.0211
168 CARDIAC MURMUR 178 0.0206
169 DYSPNOEA EXERTIONAL 756 0.0201
170 VULVAL DISORDER 13 0.0197
171 NOCTURNAL DYSPNOEA 25 0.0196
172 EOSINOPHILIA 340 0.0194
173 EMPHYSEMA 188 0.0186
174 BREAST NEOPLASM 19 0.0184
175 BLOOD TEST ABNORMAL 258 0.0183
176 VACCINATION COMPLICATION 15 0.0183
177 GRANULOMA 62 0.0179
178 SENSITIVITY TO WEATHER CHANGE 94 0.0178
179 CROUP INFECTIOUS 14 0.0178
180 JOINT WARMTH 22 0.0176
181 RESPIRATORY RATE INCREASED 156 0.0176
182 LUNG OPACITY 46 0.0174
183 SPUTUM RETENTION 17 0.0172
184 ASTHMATIC CRISIS 62 0.0170
185 INCORRECT DOSE ADMINISTERED BY PRODUCT 27 0.0169
186 VASCULITIS 196 0.0168
187 VENTRICULAR HYPOKINESIA 54 0.0168
188 NASAL SEPTUM DEVIATION 32 0.0164
189 BODY MASS INDEX INCREASED 22 0.0163
190 SECRETION DISCHARGE 202 0.0161
191 BRONCHITIS BACTERIAL 12 0.0159
192 SEASONAL ALLERGY 223 0.0157
193 FEAR OF DISEASE 28 0.0157
194 RESPIRATORY TRACT CONGESTION 247 0.0155
195 SLEEP APNOEA SYNDROME 296 0.0155
196 GOUTY ARTHRITIS 12 0.0150
197 ISCHAEMIC CARDIOMYOPATHY 45 0.0147
198 UPPER AIRWAY OBSTRUCTION 13 0.0147
199 SNORING 55 0.0145
200 NASAL DISORDER 38 0.0143
201 PULMONARY MASS 212 0.0142
202 ATELECTASIS 137 0.0142
203 HYPERSENSITIVITY PNEUMONITIS 16 0.0140
204 MACROCYTOSIS 16 0.0138
205 BLOOD PRESSURE SYSTOLIC INCREASED 269 0.0138
206 EYE ALLERGY 21 0.0135
207 UPPER RESPIRATORY TRACT CONGESTION 39 0.0135
208 BRONCHOSPASM 192 0.0134
209 ANGIOPLASTY 20 0.0134
210 MEAN CELL HAEMOGLOBIN DECREASED 24 0.0131
211 HYPOXIA 461 0.0131
212 LEFT VENTRICULAR HYPERTROPHY 56 0.0131
213 DECREASED ACTIVITY 141 0.0131
214 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 682 0.0131
215 HYPERCHOLESTEROLAEMIA 125 0.0129
216 RESPIRATORY DISORDER 387 0.0129
217 RESPIRATION ABNORMAL 89 0.0129
218 PNEUMONIA STREPTOCOCCAL 14 0.0128
219 GINGIVAL DISORDER 48 0.0125
220 SUBCLAVIAN VEIN THROMBOSIS 14 0.0123
221 STRIDOR 36 0.0122
222 DYSLIPIDAEMIA 62 0.0122
223 ADRENAL INSUFFICIENCY 147 0.0121
224 CHEST DISCOMFORT 1221 0.0119
225 NASAL CONGESTION 697 0.0118
226 NASAL OEDEMA 21 0.0116
227 CUSHINGOID 37 0.0115
228 LOWER RESPIRATORY TRACT INFECTION 524 0.0115
229 GLAUCOMA 219 0.0114
230 SUFFOCATION FEELING 28 0.0113
231 OBSTRUCTION 44 0.0110
232 HAEMOPTYSIS 304 0.0109
233 PULMONARY CONGESTION 141 0.0107
234 POLYP 69 0.0105
235 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 25 0.0105
236 HAEMATOCRIT INCREASED 24 0.0105
237 PULMONARY FIBROSIS 202 0.0105
238 TONGUE OEDEMA 39 0.0102
239 BLOOD PRESSURE DIASTOLIC ABNORMAL 26 0.0102
240 RED BLOOD CELL COUNT INCREASED 28 0.0101
241 BUNDLE BRANCH BLOCK LEFT 43 0.0101
242 DYSPNOEA AT REST 29 0.0100
243 MYCOBACTERIAL INFECTION 17 0.0099
244 SCOLIOSIS 61 0.0098
245 APLASTIC ANAEMIA 51 0.0098
246 GASTROOESOPHAGEAL REFLUX DISEASE 786 0.0098
247 HYPOTHYROIDISM 309 0.0097
248 OBESITY 154 0.0097
249 FRUSTRATION TOLERANCE DECREASED 78 0.0096
250 BLADDER DISCOMFORT 12 0.0096
251 RESPIRATORY TRACT INFECTION 247 0.0095
252 MICTURITION URGENCY 108 0.0094
253 INCREASED UPPER AIRWAY SECRETION 48 0.0093
254 HYPOSMIA 14 0.0093
255 BRONCHOPULMONARY ASPERGILLOSIS 72 0.0093
256 COUGH 2598 0.0093
257 SPINAL CORD COMPRESSION 36 0.0092
258 SINUS DISORDER 183 0.0092
259 ORAL PRURITUS 21 0.0091
260 SCHIZOPHRENIA 111 0.0091
261 LUNG DISORDER 447 0.0091
262 BLOOD PRESSURE DIASTOLIC INCREASED 41 0.0089
263 SINUS CONGESTION 120 0.0089
264 CARBON DIOXIDE INCREASED 12 0.0088
265 OTITIS MEDIA 29 0.0088
266 AFFECTIVE DISORDER 69 0.0088
267 OROPHARYNGEAL DISCOMFORT 79 0.0087
268 VOCAL CORD DISORDER 17 0.0086
269 DYSPNOEA 4692 0.0083
270 BRONCHITIS 613 0.0083
271 VIRAL INFECTION 275 0.0083
272 SYNOVITIS 149 0.0083
273 TENDERNESS 86 0.0082
274 GESTATIONAL DIABETES 39 0.0082
275 MULTIPLE ALLERGIES 64 0.0082
276 BLOOD PRESSURE DIASTOLIC DECREASED 60 0.0081
277 SKIN LESION 221 0.0080
278 LUNG NEOPLASM 34 0.0080
279 EOSINOPHILIC OESOPHAGITIS 22 0.0079
280 FIBROMYALGIA 193 0.0079
281 HYPERVENTILATION 46 0.0079
282 LUNG INFILTRATION 67 0.0076
283 SNEEZING 170 0.0076
284 SINUSITIS 773 0.0075
285 ORAL DISORDER 55 0.0075
286 BLOOD PRESSURE SYSTOLIC DECREASED 34 0.0075
287 OTORRHOEA 13 0.0074
288 ABSCESS INTESTINAL 16 0.0074
289 INFUSION SITE BRUISING 16 0.0074
290 ORAL CANDIDIASIS 97 0.0074
291 MITRAL VALVE DISEASE 13 0.0073
292 C-REACTIVE PROTEIN ABNORMAL 47 0.0073
293 DYSPHONIA 418 0.0071
294 LABYRINTHITIS 18 0.0071
295 IRON DEFICIENCY 32 0.0071
296 PHARYNGEAL ERYTHEMA 15 0.0071
297 OXYGEN SATURATION ABNORMAL 20 0.0070
298 BRONCHITIS CHRONIC 17 0.0070
299 NONSPECIFIC REACTION 38 0.0069
300 RED CELL DISTRIBUTION WIDTH INCREASED 28 0.0067
301 LUNG INFECTION 104 0.0067
302 FOOD ALLERGY 51 0.0066
303 ABDOMINAL ABSCESS 29 0.0066
304 JOINT INJURY 140 0.0065
305 PULMONARY PAIN 19 0.0065
306 HIATUS HERNIA 84 0.0065
307 PNEUMONITIS 175 0.0064
308 RESPIRATORY RATE DECREASED 20 0.0064
309 INFLUENZA 701 0.0063
310 CORONARY ARTERY DISEASE 190 0.0063
311 ABSCESS 100 0.0063
312 MICROCYTIC ANAEMIA 13 0.0062
313 PAINFUL RESPIRATION 15 0.0062
314 RHINALGIA 17 0.0062
315 POST PROCEDURAL INFECTION 50 0.0061
316 OXYGEN SATURATION DECREASED 345 0.0061
317 RASH MORBILLIFORM 17 0.0061
318 RIB FRACTURE 125 0.0061
319 NICOTINE DEPENDENCE 47 0.0060
320 ORAL PAIN 135 0.0060
321 CLAVICLE FRACTURE 23 0.0060
322 BILE DUCT STONE 19 0.0060
323 ORTHOPNOEA 19 0.0060
324 OROPHARYNGEAL PAIN 546 0.0059
325 MIDDLE EAR EFFUSION 13 0.0059
326 HERPES ZOSTER 332 0.0058
327 EXERCISE TOLERANCE DECREASED 33 0.0057
328 ARTHRITIS 450 0.0057
329 NASOPHARYNGITIS 1051 0.0057
330 OCULAR DISCOMFORT 64 0.0057
331 UPPER RESPIRATORY TRACT INFECTION 263 0.0057
332 VIRAL UPPER RESPIRATORY TRACT INFECTION 27 0.0057
333 TRANSIENT ISCHAEMIC ATTACK 191 0.0057
334 PSYCHOTIC DISORDER 167 0.0056
335 CONJUNCTIVAL HYPERAEMIA 20 0.0056
336 OVERWEIGHT 30 0.0056
337 PNEUMONIA 1798 0.0055
338 CONCOMITANT DISEASE AGGRAVATED 34 0.0055
339 CARDIOMYOPATHY 81 0.0055
340 ECZEMA 286 0.0055
341 HEART RATE INCREASED 541 0.0055
342 RHINORRHOEA 351 0.0054
343 OSTEOPENIA 82 0.0054
344 PHARYNGITIS 67 0.0054
345 CHOLELITHIASIS 175 0.0053
346 CEREBRAL THROMBOSIS 15 0.0053
347 ANKLE FRACTURE 82 0.0053
348 LEFT VENTRICULAR DYSFUNCTION 35 0.0052
349 EYELID DISORDER 12 0.0052
350 ORAL INFECTION 20 0.0051
351 BLOOD PRESSURE INCREASED 782 0.0051
352 BRONCHIOLITIS 18 0.0051
353 IMPAIRED QUALITY OF LIFE 73 0.0051
354 OESOPHAGEAL CANDIDIASIS 20 0.0050
355 HEPATOTOXICITY 111 0.0050
356 SKIN LACERATION 54 0.0050
357 ECCHYMOSIS 34 0.0050
358 FOOD INTOLERANCE 18 0.0049
359 MUSCULOSKELETAL CHEST PAIN 76 0.0049
360 HAEMATOLOGICAL INFECTION 12 0.0049
361 PNEUMONIA BACTERIAL 45 0.0049
362 OSTEOPOROSIS 200 0.0049
363 SINUS TACHYCARDIA 69 0.0049
364 PERIPHERAL VASCULAR DISORDER 25 0.0048
365 LARYNGOSPASM 13 0.0048
366 RESPIRATORY SYNCYTIAL VIRUS INFECTION 42 0.0048
367 PEPTIC ULCER 16 0.0048
368 THERAPEUTIC REACTION TIME DECREASED 14 0.0048
369 TYPE 2 DIABETES MELLITUS 161 0.0048
370 PARANASAL SINUS DISCOMFORT 18 0.0048
371 ORAL FUNGAL INFECTION 13 0.0047
372 APHONIA 66 0.0047
373 DERMATITIS ALLERGIC 59 0.0047
374 CHOKING 91 0.0047
375 POOR QUALITY SLEEP 100 0.0046
376 ENDOTRACHEAL INTUBATION 13 0.0046
377 POST-TRAUMATIC STRESS DISORDER 31 0.0046
378 PULMONARY EMBOLISM 438 0.0046
379 LIMB INJURY 125 0.0046
380 WRIST FRACTURE 55 0.0046
381 TEMPERATURE INTOLERANCE 47 0.0046
382 THROMBOSIS 366 0.0045
383 BLOOD CHOLESTEROL ABNORMAL 21 0.0045
384 LIGAMENT RUPTURE 20 0.0045
385 KIDNEY INFECTION 88 0.0045
386 EAR DISCOMFORT 46 0.0045
387 ILLNESS 459 0.0045
388 THYROID MASS 17 0.0044
389 LIVER FUNCTION TEST ABNORMAL 128 0.0044
390 LYMPHOPENIA 62 0.0044
391 LUNG NEOPLASM MALIGNANT 180 0.0044
392 BLOOD BILIRUBIN INCREASED 118 0.0044
393 PHARYNGEAL SWELLING 42 0.0043
394 EAR INFECTION 114 0.0043
395 BLOOD CHOLESTEROL INCREASED 199 0.0043
396 INFUSION SITE HAEMORRHAGE 14 0.0043
397 QUALITY OF LIFE DECREASED 57 0.0042
398 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 23 0.0042
399 THROAT IRRITATION 189 0.0042
400 SPINAL OSTEOARTHRITIS 37 0.0042
401 BLOOD URIC ACID INCREASED 24 0.0042
402 RENAL CYST 33 0.0042
403 GASTROENTERITIS VIRAL 75 0.0041
404 TOOTH ABSCESS 42 0.0041
405 DYSPHEMIA 18 0.0041
406 STAPHYLOCOCCAL SEPSIS 20 0.0040
407 DRUG INTOLERANCE 385 0.0040
408 HEPATIC NEOPLASM 13 0.0040
409 ANGIOPATHY 22 0.0039
410 FEAR OF INJECTION 28 0.0039
411 RHINOVIRUS INFECTION 15 0.0039
412 SLEEP DISORDER 272 0.0038
413 DISEASE RECURRENCE 183 0.0038
414 SYMPTOM RECURRENCE 23 0.0038
415 INFECTION 553 0.0038
416 CONJUNCTIVITIS 70 0.0038
417 THYROID DISORDER 58 0.0038
418 PANIC REACTION 27 0.0037
419 ABDOMINAL HERNIA 17 0.0037
420 DIZZINESS POSTURAL 36 0.0037
421 HYPERSENSITIVITY 685 0.0037
422 OEDEMA PERIPHERAL 448 0.0037
423 HYPOGAMMAGLOBULINAEMIA 24 0.0036
424 SPINAL STENOSIS 15 0.0036
425 RESTLESS LEGS SYNDROME 66 0.0036
426 BLOOD PRESSURE FLUCTUATION 87 0.0036
427 SOCIAL PROBLEM 15 0.0036
428 CONDITION AGGRAVATED 1100 0.0036
429 POOR VENOUS ACCESS 37 0.0036
430 GASTROENTERITIS 52 0.0036
431 SARS-COV-2 TEST POSITIVE 47 0.0036
432 WEIGHT FLUCTUATION 37 0.0035
433 EYE PRURITUS 118 0.0035
434 ANGIOEDEMA 154 0.0035
435 EYE INFLAMMATION 33 0.0035
436 HYPERTENSION 732 0.0035
437 ARTHRITIS INFECTIVE 16 0.0034
438 HEART RATE DECREASED 119 0.0034
439 WHEELCHAIR USER 15 0.0034
440 COELIAC DISEASE 33 0.0034
441 ACCIDENT 40 0.0033
442 SKIN ATROPHY 19 0.0033
443 LYMPHOMA 51 0.0033
444 CYSTITIS 105 0.0033
445 EAR PAIN 64 0.0033
446 ASPIRATION 36 0.0033
447 ILL-DEFINED DISORDER 198 0.0033
448 CYSTIC FIBROSIS 18 0.0032
449 PARANOIA 56 0.0032
450 DISABILITY 64 0.0032
451 SENSORY LOSS 26 0.0032
452 GLUCOSE TOLERANCE IMPAIRED 19 0.0032
453 HALLUCINATION, AUDITORY 51 0.0032
454 SKIN ABRASION 15 0.0032
455 INTERVERTEBRAL DISC PROTRUSION 68 0.0031
456 WEIGHT DECREASED 867 0.0031
457 CONCUSSION 24 0.0031
458 LYMPHADENOPATHY 109 0.0031
459 NASAL DRYNESS 19 0.0030
460 SINUS HEADACHE 18 0.0030
461 HAEMORRHOIDS 59 0.0030
462 MUSCULOSKELETAL DISCOMFORT 52 0.0030
463 INFUSION SITE SWELLING 19 0.0030
464 HERNIA 58 0.0030
465 BREAST MASS 20 0.0030
466 FUNGAL INFECTION 99 0.0030
467 COLITIS MICROSCOPIC 14 0.0030
468 NEUTROPHIL COUNT INCREASED 30 0.0029
469 OCULAR HYPERAEMIA 139 0.0029
470 CARPAL TUNNEL SYNDROME 41 0.0029
471 EYE DISORDER 96 0.0029
472 IMMUNODEFICIENCY 43 0.0029
473 BLOOD IRON DECREASED 34 0.0029
474 PERIPHERAL SWELLING 441 0.0029
475 WEIGHT INCREASED 641 0.0029
476 WOUND 80 0.0029
477 RIGHT VENTRICULAR FAILURE 20 0.0029
478 DRY THROAT 29 0.0029
479 LACRIMATION INCREASED 86 0.0028
480 SCRATCH 30 0.0028
481 BODY TEMPERATURE INCREASED 58 0.0028
482 ANAPHYLACTIC REACTION 157 0.0028
483 LEUKOPENIA 141 0.0028
484 UPPER LIMB FRACTURE 56 0.0028
485 HOSPITALISATION 430 0.0028
486 TACHYPNOEA 38 0.0028
487 CLOSTRIDIUM DIFFICILE INFECTION 61 0.0028
488 MENSTRUAL DISORDER 23 0.0028
489 PARAESTHESIA ORAL 40 0.0028
490 RENAL PAIN 29 0.0027
491 EXTRASYSTOLES 19 0.0027
492 MUSCLE DISORDER 22 0.0027
493 PHOTOPHOBIA 51 0.0027
494 FOOT FRACTURE 51 0.0027
495 DIABETES MELLITUS 205 0.0027
496 CARDIOMEGALY 33 0.0027
497 NIGHT SWEATS 86 0.0027
498 OSTEOARTHRITIS 113 0.0027
499 ADVERSE DRUG REACTION 239 0.0027
500 MALAISE 1166 0.0027
501 ACUTE RESPIRATORY FAILURE 51 0.0026
502 TENDON PAIN 20 0.0026
503 HYPERVOLAEMIA 13 0.0026
504 BACTERIAL INFECTION 49 0.0026
505 THROAT TIGHTNESS 71 0.0026
506 ORGANISING PNEUMONIA 13 0.0026
507 FOOD POISONING 14 0.0026
508 JOINT SWELLING 312 0.0026
509 TOOTH INFECTION 34 0.0026
510 HYPOPHOSPHATAEMIA 19 0.0026
511 PSEUDOMONAS INFECTION 22 0.0026
512 APPETITE DISORDER 17 0.0026
513 PYELONEPHRITIS 22 0.0025
514 LIGAMENT SPRAIN 25 0.0025
515 CATARACT 150 0.0025
516 ATRIAL FIBRILLATION 243 0.0025
517 CANDIDA INFECTION 42 0.0025
518 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15 0.0025
519 VITAMIN D DEFICIENCY 24 0.0025
520 TOXIC EPIDERMAL NECROLYSIS 37 0.0024
521 ANXIETY 688 0.0024
522 BACK INJURY 26 0.0024
523 TREATMENT NONCOMPLIANCE 130 0.0024
524 LIP SWELLING 79 0.0024
525 INFUSION SITE ERYTHEMA 20 0.0024
526 BLOOD PRESSURE DECREASED 157 0.0024
527 URTICARIA 392 0.0023
528 SWOLLEN TONGUE 73 0.0023
529 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 421 0.0023
530 SCIATICA 37 0.0023
531 OESOPHAGITIS 25 0.0023
532 RASH ERYTHEMATOUS 109 0.0023
533 URINARY RETENTION 76 0.0023
534 INTERSTITIAL LUNG DISEASE 110 0.0023
535 SPINAL FRACTURE 45 0.0022
536 CONTUSION 215 0.0022
537 POSTOPERATIVE WOUND INFECTION 15 0.0022
538 PALPITATIONS 260 0.0022
539 HAEMATURIA 76 0.0022
540 TACHYCARDIA 197 0.0022
541 MYALGIA 375 0.0022
542 EYE SWELLING 82 0.0022
543 DISCOMFORT 134 0.0022
544 PAIN IN EXTREMITY 647 0.0022
545 PLEURISY 13 0.0022
546 ODYNOPHAGIA 13 0.0022
547 HEPATIC ENZYME INCREASED 146 0.0021
548 DEFAECATION URGENCY 15 0.0021
549 SPEECH DISORDER 112 0.0021
550 ANAL INCONTINENCE 19 0.0021
551 THERAPEUTIC RESPONSE DECREASED 127 0.0021
552 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 15 0.0021
553 BLOOD MAGNESIUM DECREASED 18 0.0021
554 RESPIRATORY ARREST 57 0.0021
555 ESCHERICHIA INFECTION 17 0.0021
556 C-REACTIVE PROTEIN INCREASED 75 0.0021
557 PYREXIA 711 0.0021
558 SKIN INFECTION 23 0.0020
559 IMMUNOSUPPRESSION 18 0.0020
560 PHARYNGITIS STREPTOCOCCAL 22 0.0020
561 OEDEMA 110 0.0020
562 RECTAL HAEMORRHAGE 87 0.0020
563 DIVERTICULITIS 56 0.0020
564 PNEUMOTHORAX 32 0.0020
565 RENAL DISORDER 94 0.0020
566 SENSATION OF FOREIGN BODY 17 0.0020
567 CYST 25 0.0020
568 CHEST PAIN 373 0.0020
569 GENERAL PHYSICAL HEALTH DETERIORATION 232 0.0020
570 ANOSMIA 29 0.0020
571 CARDIAC DISORDER 187 0.0020
572 RESPIRATORY DISTRESS 55 0.0020
573 PAROSMIA 15 0.0020
574 CELLULITIS 100 0.0020
575 BACK PAIN 454 0.0020
576 PHOTOSENSITIVITY REACTION 32 0.0019
577 FLANK PAIN 18 0.0019
578 SWELLING FACE 125 0.0019
579 PULMONARY HAEMORRHAGE 15 0.0019
580 BLADDER DISORDER 19 0.0019
581 MIGRAINE 182 0.0019
582 IMMUNE SYSTEM DISORDER 25 0.0019
583 GAIT INABILITY 63 0.0019
584 CARDIAC OPERATION 16 0.0019
585 DRUG EFFECT INCOMPLETE 67 0.0018
586 LIMB DISCOMFORT 57 0.0018
587 IRON DEFICIENCY ANAEMIA 17 0.0018
588 DIVERTICULUM 13 0.0018
589 DYSPEPSIA 178 0.0018
590 TENDONITIS 28 0.0018
591 HYPERTHYROIDISM 26 0.0018
592 FEELING HOT 110 0.0018
593 GALLBLADDER DISORDER 32 0.0018
594 PULMONARY OEDEMA 80 0.0018
595 ANGINA PECTORIS 51 0.0018
596 LOCALISED INFECTION 43 0.0018
597 PERICARDIAL EFFUSION 41 0.0018
598 FALL 587 0.0018
599 ANAPHYLACTIC SHOCK 45 0.0017
600 LARGE INTESTINE POLYP 12 0.0017
601 GASTROINTESTINAL PAIN 19 0.0017
602 HEART RATE IRREGULAR 39 0.0017
603 HAEMORRHAGE 180 0.0017
604 DECUBITUS ULCER 14 0.0017
605 DEPRESSION 383 0.0017
606 GAIT DISTURBANCE 322 0.0017
607 NEPHROLITHIASIS 77 0.0017
608 BLOOD GLUCOSE ABNORMAL 31 0.0017
609 SWELLING 157 0.0017
610 FATIGUE 1303 0.0017
611 INSOMNIA 445 0.0017
612 NERVOUSNESS 87 0.0017
613 BURSITIS 20 0.0016
614 NOCTURIA 20 0.0016
615 WOUND INFECTION 18 0.0016
616 AUTOIMMUNE DISORDER 16 0.0016
617 AGGRESSION 82 0.0016
618 HEADACHE 1020 0.0016
619 ABDOMINAL PAIN 378 0.0016
620 INJECTION SITE DISCOMFORT 17 0.0016
621 STOMATITIS 98 0.0016
622 TOOTHACHE 29 0.0016
623 BLOOD CALCIUM INCREASED 14 0.0016
624 PRODUCT DOSE OMISSION ISSUE 468 0.0016
625 HEAD DISCOMFORT 28 0.0016
626 FEEDING DISORDER 32 0.0016
627 SPINAL COMPRESSION FRACTURE 13 0.0016
628 MOUTH ULCERATION 33 0.0016
629 GASTROINTESTINAL INFECTION 14 0.0016
630 BLOOD PRESSURE ABNORMAL 31 0.0016
631 COLITIS 59 0.0016
632 MOBILITY DECREASED 111 0.0015
633 ARTHRALGIA 641 0.0015
634 ARRHYTHMIA 73 0.0015
635 VENTRICULAR EXTRASYSTOLES 16 0.0015
636 GASTROINTESTINAL DISORDER 138 0.0015
637 PLATELET COUNT INCREASED 20 0.0015
638 ROAD TRAFFIC ACCIDENT 64 0.0015
639 MUCOSAL INFLAMMATION 40 0.0015
640 CHILLS 179 0.0015
641 SYNCOPE 151 0.0015
642 EYE INFECTION 17 0.0015
643 NECK PAIN 84 0.0015
644 THYROID CANCER 18 0.0015
645 ACUTE MYOCARDIAL INFARCTION 44 0.0015
646 INTRAOCULAR PRESSURE INCREASED 19 0.0015
647 VERTIGO 90 0.0015
648 BASAL CELL CARCINOMA 23 0.0015
649 PURPURA 13 0.0015
650 PULMONARY THROMBOSIS 16 0.0015
651 ASTHENIA 551 0.0015
652 HYPERAESTHESIA 12 0.0015
653 INFLUENZA LIKE ILLNESS 120 0.0015
654 HAEMARTHROSIS 13 0.0014
655 HYPOKINESIA 21 0.0014
656 HEAVY MENSTRUAL BLEEDING 13 0.0014
657 CARDIAC FAILURE CONGESTIVE 116 0.0014
658 HYPERTENSIVE CRISIS 16 0.0014
659 ANAEMIA 274 0.0014
660 HUNGER 20 0.0014
661 MASS 20 0.0014
662 VITREOUS FLOATERS 14 0.0014
663 MUSCLE TIGHTNESS 23 0.0014
664 JOINT DISLOCATION 15 0.0014
665 CHROMATURIA 32 0.0014
666 COVID-19 248 0.0014
667 DIABETES MELLITUS INADEQUATE CONTROL 25 0.0014
668 HAEMATOCRIT DECREASED 28 0.0014
669 PAIN 862 0.0014
670 DERMATITIS CONTACT 16 0.0014
671 SKIN IRRITATION 64 0.0014
672 SKIN EXFOLIATION 117 0.0014
673 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
674 LEUKAEMIA 13 0.0014
675 TINNITUS 63 0.0014
676 BLOOD URINE PRESENT 26 0.0014
677 GROIN PAIN 12 0.0014
678 PARAESTHESIA 214 0.0014
679 COVID-19 PNEUMONIA 16 0.0014
680 EPISTAXIS 101 0.0013
681 PRODUCT USE ISSUE 253 0.0013
682 SINUS BRADYCARDIA 13 0.0013
683 GOUT 24 0.0013
684 GASTRITIS 35 0.0013
685 MYOCARDIAL INFARCTION 232 0.0013
686 THERAPY CHANGE 13 0.0013
687 FRACTURE 25 0.0013
688 DRY MOUTH 107 0.0013
689 THERAPEUTIC PRODUCT EFFECT DECREASED 59 0.0013
690 DIZZINESS 657 0.0013
691 RESPIRATORY DEPRESSION 16 0.0013
692 COLD SWEAT 23 0.0013
693 PHARYNGEAL OEDEMA 20 0.0013
694 INCORRECT DOSE ADMINISTERED BY DEVICE 34 0.0013
695 BACK DISORDER 21 0.0013
696 EXPOSURE DURING PREGNANCY 80 0.0013
697 PRODUCT ADMINISTRATION ERROR 26 0.0013
698 PRURITUS 494 0.0013
699 ERYTHEMA 263 0.0013
700 MATERNAL EXPOSURE DURING PREGNANCY 114 0.0013
701 WHITE BLOOD CELL COUNT INCREASED 49 0.0013
702 HYPOCALCAEMIA 24 0.0013
703 URINARY TRACT INFECTION 216 0.0013
704 HOT FLUSH 95 0.0013
705 PARALYSIS 18 0.0013
706 EYE DISCHARGE 13 0.0012
707 POST PROCEDURAL COMPLICATION 24 0.0012
708 INFLAMMATION 64 0.0012
709 HAEMATOMA 32 0.0012
710 BONE PAIN 72 0.0012
711 VOMITING 576 0.0012
712 MEMORY IMPAIRMENT 168 0.0012
713 DRY EYE 61 0.0012
714 JOINT STIFFNESS 32 0.0012
715 OSTEOMYELITIS 22 0.0012
716 MOVEMENT DISORDER 39 0.0012
717 HEREDITARY ANGIOEDEMA 13 0.0012
718 HYPOACUSIS 52 0.0012
719 PULMONARY HYPERTENSION 25 0.0012
720 SKIN DISORDER 40 0.0012
721 BLOOD POTASSIUM DECREASED 36 0.0012
722 DRUG INEFFECTIVE 1573 0.0012
723 RESPIRATORY FAILURE 87 0.0012
724 ABDOMINAL DISTENSION 124 0.0012
725 FACE OEDEMA 20 0.0012
726 HEPATIC STEATOSIS 22 0.0012
727 TOOTH FRACTURE 13 0.0012
728 MUSCULOSKELETAL STIFFNESS 103 0.0012
729 PANCREATITIS 62 0.0012
730 INITIAL INSOMNIA 12 0.0012
731 TOOTH DISORDER 26 0.0012
732 SKIN CANCER 25 0.0012
733 GASTRIC ULCER 22 0.0012
734 CONTRAINDICATED PRODUCT ADMINISTERED 35 0.0012
735 POLLAKIURIA 48 0.0011
736 VISION BLURRED 158 0.0011
737 HYPOMAGNESAEMIA 16 0.0011
738 EYE IRRITATION 66 0.0011
739 THERAPEUTIC RESPONSE SHORTENED 38 0.0011
740 INTESTINAL OBSTRUCTION 43 0.0011
741 HYPOGLYCAEMIA 55 0.0011
742 ACUTE RESPIRATORY DISTRESS SYNDROME 20 0.0011
743 HYPOAESTHESIA ORAL 17 0.0011
744 HAEMATOCHEZIA 62 0.0011
745 HEMIPARESIS 19 0.0011
746 MALIGNANT MELANOMA 15 0.0011
747 INJECTION SITE WARMTH 23 0.0011
748 PROCEDURAL PAIN 31 0.0011
749 PRURITUS GENERALISED 24 0.0011
750 HEAD INJURY 35 0.0011
751 EYE PAIN 62 0.0011
752 RHEUMATOID ARTHRITIS 124 0.0011
753 ROTATOR CUFF SYNDROME 14 0.0011
754 INFUSION SITE PAIN 14 0.0011
755 POLYNEUROPATHY 13 0.0011
756 DECREASED APPETITE 252 0.0011
757 FOOT DEFORMITY 12 0.0011
758 ORAL HERPES 21 0.0011
759 FREQUENT BOWEL MOVEMENTS 29 0.0011
760 ABDOMINAL DISCOMFORT 180 0.0011
761 FISTULA 12 0.0011
762 MUSCLE SPASMS 195 0.0011
763 PRODUCT USE IN UNAPPROVED INDICATION 263 0.0011
764 PRODUCT AVAILABILITY ISSUE 24 0.0011
765 INJECTION SITE EXTRAVASATION 13 0.0011
766 TENDON RUPTURE 13 0.0011
767 MUSCULOSKELETAL PAIN 55 0.0010
768 OESOPHAGEAL CARCINOMA 31 0.0010
769 INJECTION SITE SWELLING 80 0.0010
770 BONE DISORDER 19 0.0010
771 HYPOKALAEMIA 48 0.0010
772 HYPOAESTHESIA 155 0.0010
773 OSTEONECROSIS 34 0.0010
774 POISONING 13 0.0010
775 ELECTROLYTE IMBALANCE 12 0.0010
776 DEAFNESS 27 0.0010
777 MENTAL IMPAIRMENT 25 0.0010
778 COLITIS ULCERATIVE 46 0.0010
779 PALLOR 28 0.0010
780 NAUSEA 814 0.0010
781 IMPAIRED GASTRIC EMPTYING 14 0.0010
782 HYPOTENSION 206 0.0010
783 PAIN IN JAW 29 0.0010
784 FEELING ABNORMAL 244 0.0010
785 SKIN HAEMORRHAGE 15 0.0010
786 DELIRIUM 35 0.0010
787 ORAL DISCOMFORT 14 0.0010
788 DEPRESSED MOOD 53 0.0010
789 PROTEINURIA 19 0.0010
790 LEUKOCYTOSIS 18 0.0010
791 DYSSTASIA 29 0.0010
792 CRYING 36 0.0010
793 PANIC ATTACK 36 0.0010
794 FLUSHING 100 0.0010
795 THERAPEUTIC RESPONSE UNEXPECTED 44 0.0010
796 HYPERCALCAEMIA 12 0.0010
797 FLATULENCE 55 0.0010
798 MUSCULAR WEAKNESS 110 0.0010
799 TREMOR 160 0.0010
800 GASTRIC DISORDER 33 0.0010
801 OFF LABEL USE 837 0.0010
802 GINGIVAL BLEEDING 13 0.0010
803 ABDOMINAL PAIN LOWER 24 0.0009
804 ARTHROPATHY 52 0.0009
805 LOSS OF CONSCIOUSNESS 119 0.0009
806 ABDOMINAL PAIN UPPER 190 0.0009
807 DEVICE FAILURE 14 0.0009
808 INJECTION SITE PRURITUS 61 0.0009
809 PROSTATE CANCER 73 0.0009
810 DYSPHAGIA 86 0.0009
811 HIP FRACTURE 29 0.0009
812 EYE HAEMORRHAGE 12 0.0009
813 SOMNOLENCE 180 0.0009
814 FEBRILE NEUTROPENIA 59 0.0009
815 LETHARGY 51 0.0009
816 IRRITABLE BOWEL SYNDROME 19 0.0009
817 RASH PRURITIC 48 0.0009
818 RASH 385 0.0009
819 ALOPECIA 172 0.0009
820 DIARRHOEA 565 0.0009
821 MENTAL DISORDER 38 0.0009
822 DISTURBANCE IN ATTENTION 47 0.0009
823 SEPSIS 97 0.0009
824 DYSURIA 32 0.0009
825 CHRONIC KIDNEY DISEASE 66 0.0009
826 NEURALGIA 21 0.0009
827 FEELING COLD 24 0.0009
828 DERMATITIS 18 0.0009
829 INCORRECT DOSE ADMINISTERED 196 0.0009
830 CONSTIPATION 187 0.0009
831 BLOOD SODIUM DECREASED 16 0.0008
832 CARDIAC FAILURE 67 0.0008
833 BALANCE DISORDER 72 0.0008
834 FAECES DISCOLOURED 18 0.0008
835 INJECTION SITE BRUISING 66 0.0008
836 ABORTION SPONTANEOUS 33 0.0008
837 DYSARTHRIA 31 0.0008
838 MOOD SWINGS 26 0.0008
839 MULTIPLE SCLEROSIS 39 0.0008
840 INJECTION SITE URTICARIA 20 0.0008
841 BURNING SENSATION 57 0.0008
842 URINARY INCONTINENCE 24 0.0008
843 HAEMOGLOBIN DECREASED 83 0.0008
844 PLEURAL EFFUSION 49 0.0008
845 CONFUSIONAL STATE 130 0.0008
846 HYPERGLYCAEMIA 29 0.0008
847 IMPAIRED WORK ABILITY 17 0.0008
848 HYPERHIDROSIS 101 0.0008
849 INJECTION SITE ERYTHEMA 97 0.0008
850 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
851 DIPLOPIA 20 0.0008
852 MOOD ALTERED 21 0.0008
853 KNEE ARTHROPLASTY 16 0.0008
854 THERAPY CESSATION 39 0.0008
855 CEREBROVASCULAR ACCIDENT 128 0.0008
856 DEVICE DEFECTIVE 13 0.0007
857 BLOOD GLUCOSE DECREASED 36 0.0007
858 ORTHOSTATIC HYPOTENSION 13 0.0007
859 RENAL FAILURE 99 0.0007
860 PRESYNCOPE 18 0.0007
861 VISUAL IMPAIRMENT 91 0.0007
862 HYPERSOMNIA 21 0.0007
863 LOWER LIMB FRACTURE 14 0.0007
864 INJECTION SITE HAEMORRHAGE 58 0.0007
865 INJECTION SITE PAIN 219 0.0007
866 BLISTER 40 0.0007
867 FLUID RETENTION 36 0.0007
868 JAUNDICE 19 0.0007
869 PRODUCT SUBSTITUTION ISSUE 40 0.0007
870 DYSGEUSIA 51 0.0007
871 RASH MACULAR 24 0.0007
872 INCREASED APPETITE 13 0.0007
873 EMOTIONAL DISTRESS 82 0.0007
874 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 137 0.0007
875 ERUCTATION 13 0.0007
876 BONE DENSITY DECREASED 21 0.0007
877 RASH PAPULAR 15 0.0007
878 LIVER DISORDER 29 0.0007
879 PNEUMONIA ASPIRATION 16 0.0006
880 BLINDNESS 26 0.0006
881 SKIN DISCOLOURATION 29 0.0006
882 DISORIENTATION 25 0.0006
883 RENAL IMPAIRMENT 53 0.0006
884 RESTLESSNESS 23 0.0006
885 HYPOPHAGIA 16 0.0006
886 DEHYDRATION 82 0.0006
887 RETCHING 13 0.0006
888 APHASIA 18 0.0006
889 METABOLIC ACIDOSIS 19 0.0006
890 CARDIOVASCULAR DISORDER 15 0.0006
891 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
892 HYPONATRAEMIA 33 0.0006
893 AGITATION 43 0.0006
894 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
895 STAPHYLOCOCCAL INFECTION 19 0.0006
896 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
897 INTENTIONAL PRODUCT USE ISSUE 49 0.0006
898 FEAR 15 0.0006
899 HALLUCINATION 42 0.0006
900 NEUROPATHY PERIPHERAL 53 0.0006
901 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
902 UNEVALUABLE EVENT 42 0.0006
903 INJURY 39 0.0006
904 NEOPLASM MALIGNANT 37 0.0006
905 SEIZURE 64 0.0006
906 NEEDLE ISSUE 16 0.0005
907 IRRITABILITY 33 0.0005
908 IMPAIRED HEALING 18 0.0005
909 BRADYCARDIA 29 0.0005
910 CARDIAC ARREST 45 0.0005
911 NEUTROPENIA 74 0.0005
912 HYPERKALAEMIA 19 0.0005
913 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 25 0.0005
914 OSTEONECROSIS OF JAW 13 0.0005
915 RED BLOOD CELL COUNT DECREASED 15 0.0005
916 INJECTION SITE RASH 16 0.0005
917 AGEUSIA 13 0.0005
918 NIGHTMARE 18 0.0005
919 EMOTIONAL DISORDER 16 0.0005
920 INJECTION SITE MASS 19 0.0005
921 INFUSION RELATED REACTION 34 0.0005
922 HAEMATEMESIS 13 0.0005
923 DEVICE MALFUNCTION 36 0.0005
924 SEPTIC SHOCK 22 0.0005
925 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
926 TREATMENT FAILURE 41 0.0005
927 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
928 DEEP VEIN THROMBOSIS 32 0.0005
929 INTENTIONAL DOSE OMISSION 14 0.0005
930 AMNESIA 31 0.0005
931 PSORIATIC ARTHROPATHY 19 0.0005
932 NEUTROPHIL COUNT DECREASED 19 0.0005
933 DEMENTIA 13 0.0005
934 BREAST CANCER 43 0.0005
935 DRUG INTERACTION 72 0.0005
936 EXPIRED PRODUCT ADMINISTERED 15 0.0005
937 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
938 BLOOD CREATININE INCREASED 29 0.0004
939 SURGERY 26 0.0004
940 PSORIASIS 57 0.0004
941 ABNORMAL DREAMS 12 0.0004
942 DEATH 369 0.0004
943 COGNITIVE DISORDER 20 0.0004
944 THERAPY INTERRUPTED 30 0.0004
945 INJECTION SITE REACTION 28 0.0004
946 LABORATORY TEST ABNORMAL 12 0.0004
947 SUICIDAL IDEATION 37 0.0004
948 COMA 19 0.0004
949 EPILEPSY 12 0.0004
950 ACUTE KIDNEY INJURY 60 0.0004
951 VISUAL ACUITY REDUCED 13 0.0004
952 PRODUCT DOSE OMISSION 24 0.0004
953 CEREBRAL HAEMORRHAGE 13 0.0004
954 ASPARTATE AMINOTRANSFERASE INCREASED 19 0.0004
955 BLOOD GLUCOSE INCREASED 67 0.0004
956 ABNORMAL BEHAVIOUR 14 0.0004
957 EXTRA DOSE ADMINISTERED 14 0.0003
958 VAGINAL HAEMORRHAGE 15 0.0003
959 ACNE 26 0.0003
960 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
961 DISEASE PROGRESSION 40 0.0003
962 DRY SKIN 45 0.0003
963 ADVERSE EVENT 31 0.0003
964 DYSKINESIA 13 0.0003
965 PRODUCT QUALITY ISSUE 43 0.0003
966 RHABDOMYOLYSIS 13 0.0003
967 THERAPY NON-RESPONDER 14 0.0003
968 INTENTIONAL PRODUCT MISUSE 27 0.0003
969 DRUG EFFECT DECREASED 16 0.0003
970 THROMBOCYTOPENIA 32 0.0003
971 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
972 DRUG ABUSE 23 0.0003
973 MEDICATION ERROR 15 0.0003
974 DEVICE ISSUE 23 0.0003
975 SKIN BURNING SENSATION 18 0.0003
976 ACCIDENTAL EXPOSURE TO PRODUCT 25 0.0002
977 GASTROINTESTINAL HAEMORRHAGE 20 0.0002
978 OVERDOSE 51 0.0002
979 DRUG DEPENDENCE 37 0.0002
980 CONVULSION 13 0.0002
981 PLATELET COUNT DECREASED 23 0.0002
982 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
983 UNDERDOSE 13 0.0002
984 DRUG DOSE OMISSION 29 0.0002
985 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
986 TOXICITY TO VARIOUS AGENTS 21 0.0001
987 NO ADVERSE EVENT 16 0.0001